Dioxin-induced fetal growth retardation

the role of a preceding attenuation in the circulating level of glucocorticoid

Yukiko Hattori, Tomoki Takeda, Misaki Fujii, Junki Taura, Yuji Ishii, Hideyuki Yamada

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Exposure of pregnant rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) at a low dose causes developmental disorders such as growth retardation and sexual immaturity in their pups. Our previous studies have demonstrated that TCDD attenuates the expression of pituitary luteinizing hormone in fetuses, resulting in the impairment of sexual behavior after they reach maturity. In this study, we focused on growth disturbance and investigated whether TCDD affects the expression of growth hormone (GH), another pituitary hormone which is essential for normal development in perinatal pups. The result showed that maternal exposure to TCDD (1 µg/kg) at gestational day (GD) 15 reduced the fetal expression of GH from the onset at GD18. In accordance with this, TCDD attenuated the pup weight during the perinatal period. We then examined the effect of TCDD on the serum concentration of corticosterone, which plays a key role in the proliferation of GH-producing cells, and found that TCDD reduces the circulating level of corticosterone in the mothers at GD18 and the male fetuses at GD19. The reduction in fetuses seems to be due to increased inactivation rather than reduced synthesis, because TCDD induces the fetal expression of hepatic enzymes participating in the metabolism of glucocorticoids without changing the expression of steroidogenic proteins in the pituitary–adrenal axis. Supplying corticosterone to TCDD-exposed mothers restored or tended to restore a TCDD-induced reduction in pup weight as well as the levels of pituitary GH mRNA and serum GH. These results suggest that TCDD lowers GH expression and growth retardation owing, at least partially, to a reduction in the circulating level of glucocorticoid in pregnant mothers and their fetuses.

Original languageEnglish
Pages (from-to)572-580
Number of pages9
JournalEndocrine
Volume47
Issue number2
DOIs
Publication statusPublished - Oct 21 2014

Fingerprint

Dioxins
Fetal Growth Retardation
Glucocorticoids
Growth Hormone
Fetus
Corticosterone
Pituitary Hormones
Polychlorinated Dibenzodioxins
Growth
Maternal Exposure
Weights and Measures
Luteinizing Hormone
Fetal Development
Serum
Sexual Behavior

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology

Cite this

Dioxin-induced fetal growth retardation : the role of a preceding attenuation in the circulating level of glucocorticoid. / Hattori, Yukiko; Takeda, Tomoki; Fujii, Misaki; Taura, Junki; Ishii, Yuji; Yamada, Hideyuki.

In: Endocrine, Vol. 47, No. 2, 21.10.2014, p. 572-580.

Research output: Contribution to journalArticle

Hattori, Yukiko ; Takeda, Tomoki ; Fujii, Misaki ; Taura, Junki ; Ishii, Yuji ; Yamada, Hideyuki. / Dioxin-induced fetal growth retardation : the role of a preceding attenuation in the circulating level of glucocorticoid. In: Endocrine. 2014 ; Vol. 47, No. 2. pp. 572-580.
@article{97e1215a0e964729b89453155b91ddce,
title = "Dioxin-induced fetal growth retardation: the role of a preceding attenuation in the circulating level of glucocorticoid",
abstract = "Exposure of pregnant rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) at a low dose causes developmental disorders such as growth retardation and sexual immaturity in their pups. Our previous studies have demonstrated that TCDD attenuates the expression of pituitary luteinizing hormone in fetuses, resulting in the impairment of sexual behavior after they reach maturity. In this study, we focused on growth disturbance and investigated whether TCDD affects the expression of growth hormone (GH), another pituitary hormone which is essential for normal development in perinatal pups. The result showed that maternal exposure to TCDD (1 µg/kg) at gestational day (GD) 15 reduced the fetal expression of GH from the onset at GD18. In accordance with this, TCDD attenuated the pup weight during the perinatal period. We then examined the effect of TCDD on the serum concentration of corticosterone, which plays a key role in the proliferation of GH-producing cells, and found that TCDD reduces the circulating level of corticosterone in the mothers at GD18 and the male fetuses at GD19. The reduction in fetuses seems to be due to increased inactivation rather than reduced synthesis, because TCDD induces the fetal expression of hepatic enzymes participating in the metabolism of glucocorticoids without changing the expression of steroidogenic proteins in the pituitary–adrenal axis. Supplying corticosterone to TCDD-exposed mothers restored or tended to restore a TCDD-induced reduction in pup weight as well as the levels of pituitary GH mRNA and serum GH. These results suggest that TCDD lowers GH expression and growth retardation owing, at least partially, to a reduction in the circulating level of glucocorticoid in pregnant mothers and their fetuses.",
author = "Yukiko Hattori and Tomoki Takeda and Misaki Fujii and Junki Taura and Yuji Ishii and Hideyuki Yamada",
year = "2014",
month = "10",
day = "21",
doi = "10.1007/s12020-014-0257-3",
language = "English",
volume = "47",
pages = "572--580",
journal = "Endocrine",
issn = "0969-711X",
publisher = "Humana Press",
number = "2",

}

TY - JOUR

T1 - Dioxin-induced fetal growth retardation

T2 - the role of a preceding attenuation in the circulating level of glucocorticoid

AU - Hattori, Yukiko

AU - Takeda, Tomoki

AU - Fujii, Misaki

AU - Taura, Junki

AU - Ishii, Yuji

AU - Yamada, Hideyuki

PY - 2014/10/21

Y1 - 2014/10/21

N2 - Exposure of pregnant rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) at a low dose causes developmental disorders such as growth retardation and sexual immaturity in their pups. Our previous studies have demonstrated that TCDD attenuates the expression of pituitary luteinizing hormone in fetuses, resulting in the impairment of sexual behavior after they reach maturity. In this study, we focused on growth disturbance and investigated whether TCDD affects the expression of growth hormone (GH), another pituitary hormone which is essential for normal development in perinatal pups. The result showed that maternal exposure to TCDD (1 µg/kg) at gestational day (GD) 15 reduced the fetal expression of GH from the onset at GD18. In accordance with this, TCDD attenuated the pup weight during the perinatal period. We then examined the effect of TCDD on the serum concentration of corticosterone, which plays a key role in the proliferation of GH-producing cells, and found that TCDD reduces the circulating level of corticosterone in the mothers at GD18 and the male fetuses at GD19. The reduction in fetuses seems to be due to increased inactivation rather than reduced synthesis, because TCDD induces the fetal expression of hepatic enzymes participating in the metabolism of glucocorticoids without changing the expression of steroidogenic proteins in the pituitary–adrenal axis. Supplying corticosterone to TCDD-exposed mothers restored or tended to restore a TCDD-induced reduction in pup weight as well as the levels of pituitary GH mRNA and serum GH. These results suggest that TCDD lowers GH expression and growth retardation owing, at least partially, to a reduction in the circulating level of glucocorticoid in pregnant mothers and their fetuses.

AB - Exposure of pregnant rats to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) at a low dose causes developmental disorders such as growth retardation and sexual immaturity in their pups. Our previous studies have demonstrated that TCDD attenuates the expression of pituitary luteinizing hormone in fetuses, resulting in the impairment of sexual behavior after they reach maturity. In this study, we focused on growth disturbance and investigated whether TCDD affects the expression of growth hormone (GH), another pituitary hormone which is essential for normal development in perinatal pups. The result showed that maternal exposure to TCDD (1 µg/kg) at gestational day (GD) 15 reduced the fetal expression of GH from the onset at GD18. In accordance with this, TCDD attenuated the pup weight during the perinatal period. We then examined the effect of TCDD on the serum concentration of corticosterone, which plays a key role in the proliferation of GH-producing cells, and found that TCDD reduces the circulating level of corticosterone in the mothers at GD18 and the male fetuses at GD19. The reduction in fetuses seems to be due to increased inactivation rather than reduced synthesis, because TCDD induces the fetal expression of hepatic enzymes participating in the metabolism of glucocorticoids without changing the expression of steroidogenic proteins in the pituitary–adrenal axis. Supplying corticosterone to TCDD-exposed mothers restored or tended to restore a TCDD-induced reduction in pup weight as well as the levels of pituitary GH mRNA and serum GH. These results suggest that TCDD lowers GH expression and growth retardation owing, at least partially, to a reduction in the circulating level of glucocorticoid in pregnant mothers and their fetuses.

UR - http://www.scopus.com/inward/record.url?scp=84911004177&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84911004177&partnerID=8YFLogxK

U2 - 10.1007/s12020-014-0257-3

DO - 10.1007/s12020-014-0257-3

M3 - Article

VL - 47

SP - 572

EP - 580

JO - Endocrine

JF - Endocrine

SN - 0969-711X

IS - 2

ER -